Ingevity Co. (NYSE:NGVT) Shares Purchased by Southernsun Asset Management LLC

Southernsun Asset Management LLC grew its stake in Ingevity Co. (NYSE:NGVT - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 686,490 shares of the company's stock after purchasing an additional 13,171 shares during the quarter. Ingevity makes up 3.5% of Southernsun Asset Management LLC's holdings, making the stock its 16th biggest position. Southernsun Asset Management LLC owned about 1.89% of Ingevity worth $27,974,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of NGVT. American Century Companies Inc. boosted its holdings in Ingevity by 37.7% in the 4th quarter. American Century Companies Inc. now owns 1,457,365 shares of the company's stock worth $59,388,000 after buying an additional 398,800 shares during the last quarter. Royce & Associates LP lifted its position in shares of Ingevity by 22.4% in the fourth quarter. Royce & Associates LP now owns 1,142,598 shares of the company's stock valued at $46,561,000 after acquiring an additional 208,921 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Ingevity in the fourth quarter worth approximately $4,882,000. Wellington Management Group LLP increased its position in shares of Ingevity by 5.4% during the fourth quarter. Wellington Management Group LLP now owns 2,239,970 shares of the company's stock worth $91,279,000 after purchasing an additional 115,581 shares in the last quarter. Finally, Segall Bryant & Hamill LLC raised its stake in Ingevity by 8.6% in the 4th quarter. Segall Bryant & Hamill LLC now owns 1,287,281 shares of the company's stock valued at $52,457,000 after purchasing an additional 101,866 shares during the last quarter. Hedge funds and other institutional investors own 91.59% of the company's stock.

Ingevity Trading Up 0.0 %

Shares of NGVT traded up $0.01 during mid-day trading on Friday, reaching $32.86. The stock had a trading volume of 324,154 shares, compared to its average volume of 275,513. Ingevity Co. has a 52-week low of $28.49 and a 52-week high of $56.30. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of -2.78 and a beta of 1.54. The business's fifty day moving average is $39.64 and its 200 day moving average is $41.70. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04.

Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.29 by $0.66. The firm had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. On average, sell-side analysts predict that Ingevity Co. will post 4.45 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on NGVT shares. Wells Fargo & Company lowered their target price on shares of Ingevity from $45.00 to $32.00 and set an "equal weight" rating on the stock in a research note on Wednesday, April 9th. StockNews.com lowered shares of Ingevity from a "buy" rating to a "hold" rating in a research report on Saturday, April 12th. Finally, BMO Capital Markets raised shares of Ingevity from a "market perform" rating to an "outperform" rating and upped their price objective for the company from $62.00 to $65.00 in a research note on Wednesday, February 26th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $52.20.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.